Consensus McKesson Corporation

Stocks

MCK

US58155Q1031

Pharmaceuticals

Market Closed - NYSE 16:00:02 2026-08-28 EDT			5-day change	1st Jan Change
893.39 ^USD	+0.32%		+4.02%	+8.91%

08-28	McKesson Reports Cybersecurity Incident	MT
08-25	Equities Rise Despite US-Canada Trade Tensions	MT

Evolution of the Average Target: McKesson Corporation

Evolution of the Target Price: McKesson Corporation

Changes in Analyst Recommendations: McKesson Corporation

2b.AaisJOJo9QfGPVWW8sGVMFrDm_hMv48IS2N0y1eVlrY.W5rNY6QYnmSUczbip4_sXgCI1qwYy-1OExIH_hbv8Id75c9BqTyWVoIObQ~a892269ed974656bb624334a70b448cc

Analysts' recommendations: McKesson Corporation

08-19	McKesson's Specialty Drug Mix Helps Cushion Pricing Pressure, RBC Says	MT
08-19	RBC Initiates McKesson at Sector Perform With $845 Price Target	MT
08-18	Barclays Raises Price Target on McKesson to $1,000 From $925, Maintains Overweight Rating	MT
08-11	Wells Fargo Adjusts Price Target on McKesson to $933 From $812, Maintains Equalweight Rating	MT
08-06	Mizuho Adjusts Price Target on McKesson to $905 From $885	MT
08-06	TD Cowen Adjusts Price Target on McKesson to $1,006 From $989	MT
08-06	Evercore ISI Adjusts Price Target on McKesson to $1,000 From $860	MT
08-06	Baird Adjusts Price Target on McKesson to $1,015 From $955	MT
08-06	UBS Adjusts Price Target on McKesson to $1,080 From $1,050, Maintains Buy Rating	MT
08-06	BofA Securities Adjusts Price Target on McKesson to $1,050 From $950	MT
07-23	Citigroup Raises McKesson Price Target to $1,000 From $945, Maintains Buy Rating	MT
07-22	Baird Adjusts Price Target on McKesson to $955 From $941, Maintains Outperform Rating	MT
07-21	TD Cowen Adjusts McKesson Price Target to $989 From $1,012, Maintains Buy Rating	MT
07-21	BofA Securities Adjusts McKesson Price Target to $925 From $900	MT
07-14	Leerink Partners Adjusts Price Target on McKesson to $950 From $970, Maintains Outperform Rating	MT
07-07	Evercore ISI Adjusts Price Target on McKesson to $860 From $850	MT
06-10	Barclays Cuts McKesson Price Target to $925 From $1,050, Maintains Overweight Rating	MT
06-05	Argus Adjusts Price Target on McKesson to $850 From $1,050, Maintains Buy Rating	MT
05-14	Citigroup Adjusts Price Target on McKesson to $945 From $975, Maintains Buy Rating	MT
05-12	Wells Fargo Adjusts Price Target on McKesson to $812 From $925, Maintains Equalweight Rating	MT
05-08	McKesson's Fiscal 2027 Guidance 'Encouraging,' Cencora Selloff Overdone, Morgan Stanley Says	MT
05-08	UBS Adjusts McKesson Price Target to $1,050 From $1,000, Maintains Buy Rating	MT
05-08	Deutsche Bank Adjusts McKesson Price Target to $875 From $973, Maintains Buy Rating	MT
04-28	William Blair Initiates McKesson at Outperform	MT
04-22	UBS Cuts Price Target on McKesson to $1,000 From $1,012, Maintains Buy Rating	MT

More recommendations

Pharmaceuticals Wholesale

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Objective/dr gap
MCKESSON CORPORATION		+10.47%
CARDINAL HEALTH, INC.		+15.51%
SIGMA HEALTHCARE LIMITED		+19.1%
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD		+25.59%
HUADONG MEDICINE CO., LTD		+55.61%
H. LUNDBECK A/S		+17.65%
SINOPHARM GROUP CO. LTD.		+33.04%
GALENICA AG	-	+3.85%
SELÇUK ECZA DEPOSU TICARET VE SANAYI		-57.5%
MEDIPAL HOLDINGS CORPORATION		+2.31%
Average		+12.56%
Weighted average by Cap.		+13.84%